(126 days)
Not Found
No
The summary describes standard ultrasound image processing and does not mention AI, ML, or related concepts.
No
The device is a diagnostic ultrasound system used to generate images for clinical diagnosis, not to provide therapy.
Yes
The "Intended Use / Indications for Use" section states that the system "provides calculation packages that provide information to the clinician that may be used adjunctively with other medical data obtained by a physician for clinical diagnosis purposes." This directly indicates its role in aiding diagnosis.
No
The device description explicitly states that the system uses a transducer applied to the patient to generate and receive ultrasound waves, which are then processed to create an image. This involves hardware components beyond just software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The description clearly states that the device uses ultrasound waves transmitted into the human body and receives echoes back from the body to create images. This is an in vivo (within the living body) process, not an in vitro process.
- Intended Use/Indications for Use: The listed applications are all related to imaging internal structures of the body using ultrasound, which is an in vivo imaging modality.
- Lack of Mention of Samples: There is no mention of the device analyzing samples taken from the body.
Therefore, the SONIX MDP Ultrasound System is a diagnostic imaging device that operates in vivo, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The SONIX MDP Ultrasound System is intended for the following applications: Ophthalmic, Abdominal, Cardiac, Intraoperative (specific), Intraoperative Neurological, Fetal, Pediatric, Small Parts, Neonatal/ Adult Cephalic, OB/GYN, Transesophageal, Transrectal, Transvaginal, Peripheral Vascular, Musculoskeletal conventional, Musculoskeletal superficial, Pelvic, Nerve Block, Vascular Access.
The system also provides the ability to measure anatomical structures {fetal, abdominal, pediatric, small organ, cardiac, transvaginal, peripheral vessel, musculoskeletal} and provides calculation packages that provide information to the clinician that may be used adjunctively with other medical data obtained by a physician for clinical diagnosis purposes.
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Ophthalmic, Fetal, Abdominal, Intraoperative (specific), Intraoperative Neurological, Pediatric, Small Organ (specify), Neonatal Cephalic, Adult Cephalic, Cardiac, Transesophageal, Transrectal, Transvaginal, Transurethral, Intravascular, Peripheral Vascular, Laparoscopic, MSK Conventional, MSK Superficial, Vascular Access, Nerve Block.
Product codes (comma separated list FDA assigned to the subject device)
90-IYN, 90-IYO, 90-ITX
Device Description
The ultrasound plateform is similar to the predicate devices in terms of operation. A transducer is applied to the patient and the system generates ultrasound waves then transmit the wave into human body. The system then receives echoes back from human body, processes them to yield an image on a display.
Mentions image processing
The system then receives echoes back from human body, processes them to yield an image on a display.
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Ophthalmic, Abdominal, Cardiac, Neurological, Fetal, Pediatric, Small Parts (Breast, Thyroid, Testicle), Neonatal Cephalic, Adult Cephalic, OB/GYN, Transesophageal, Transrectal, Transvaginal, Peripheral Vascular, Musculoskeletal conventional, Musculoskeletal superficial, Pelvic, Vascular, Nerves.
Indicated Patient Age Range
Fetal, Pediatric, Neonatal Cephalic, Adult Cephalic.
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K053069, K042326, K061827, K062247, K060993
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
K080935
AUG - 6 2008
510 (k) Summary for the Sonix MDP Ultrasound Scanner
This summary of safety and effectiveness is provided as part of this Premarket Notification in compliance with the Safe Medical Devices Act of 1990 revisions to 21 CFR, Part 807.92, Content and format of a 510(k) summary.
1.0 Submitter Information
1.1 Submitter
Ultrasonix Medical Corporation 130-4311 Viking Way Richmond, British Columbia Canada V6V 2K9 (t) 604-437-9500 (f) 604-437-9502
1.2 Contact
Chas Yu Quality Assurance Manager Tel. (604) 279-8550 ext 152 Fax. (604) 279-8559 Email: chas.yu@ultrasonix.com
1.3 Date Prepared
April 1, 2008
2.0 Device Name
2.1 Common Name
Ultrasound Imaging System
2.2 Proprietary Name
Sonix MDP Ultrasound Scanner
2.3 Classification Name
FR Number | Product Code | |
---|---|---|
Ultrasonic Pulsed Doppler Imaging System | 892.1550 | 90-IYN |
Ultrasonic Pulsed Echo Imaging System | 892.1560 | 90-IYO |
Diagnostic Ultrasound Transducer | 892.1570 | 90-ITX |
1
2.4 Classification
Class II
2.5 Predicate Device:
SonoSite MicroMaxx High Resolution Ultrsound System (K053069) Ultrasonix Ergosonix 500 Ultrasound Scanner (K042326) SONIX Ultrasound Scanner (K061827) Philips HD 11 Diagnostic Ultrasound System (K062247) GE Logiq P5 and A5 (K060993)
2.6 Reason for submission:
Name change request
N/A
New product clearance for:
| SONIX MDP Ultrasound Scanner and Transducers: | L14-5/38
C5-2/60
EC9-5/10
SA4-2/24 |
----------------------------------------------- | --------------------------------------------- |
---|
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized emblem featuring three abstract shapes that resemble a bird in flight or flowing ribbons.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Chas Yu Quality Assurance Manager Ultrasonix Medical Corporation 130-4311 Viking Way Richmond, BC, V6V 2K9 CANADA
AUG - 6 2008
Re: K080935
Trade/Device Name: SONIX MDP Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, and ITX Dated: June 10, 2008 Received: June 19, 2008
Dear Mr. Yu:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the SONIX MDP Ultrasound System, as described in your premarket notification: .
Transducer Model Number
SA/24mm Phased Array 2.8 MHz C5-2/60 Convex 3.2 MHz 60mm Radius EC9-5/10 Microconvex Endocavity 6.6 MHz 10mm Radius L14-5/38 Linear 8 MHz 38mm
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all
3
the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.
This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G. (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.
The special report should reference the manufacturer's 510(k) number. It should be clearly and promincntly marked "ADD-TO-FILE" and should be submitted in duplicate to:
Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html
If you have any questions regarding the content of this letter, please contact Lauren Hefner at (240) 276-3666.
Sincerely yours.
Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure(s)
4
Indications for Use
510(k) Number (if known): K080935
Device Name: SONIX MDP Ultrasound System
Indications For Use:
The SONIX MDP Ultrasound System is intended for the following applications: Ophthalmic, Abdominal, Cardiac, Intraoperative (specific), Intraoperative Neurological, Fetal, Pediatric, Small Parts, Neonatal/ Adult Cephalic, OB/GYN, Transesophageal, Transrectal, Transvaginal, Peripheral Vascular, Musculoskeletal conventional, Musculoskeletal superficial, Pelvic, Nerve Block, Vascular Access.
The system also provides the ability to measure anatomical structures {fetal, abdominal, pediatric, small organ, cardiac, transvaginal, peripheral vessel, musculoskeletal} and provides calculation packages that provide information to the clinician that may be used adjunctively with other medical data obtained by a physician for clinical diagnosis purposes.
The SONIX MDP Ultrasound System indication(s) for use are the same as the predicate devices. Please see attached IFU comparison chart between SONIX MDP and the predicate devices.
The ultrasound plateform is similar to the predicate devices in terms of operation. A transducer is applied to the patient and the system generates ultrasound waves then transmit the wave into human body. The system then receives echoes back from human body, processes them to yield an image on a display.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Division of Reproductive, Abdominal and Radiological Devices 510(k) Number _
Page 1 of 1
5
ULTRASOUND INDICATIONS FOR USE TABLES
SONIX MDP Ultrasound Scanner – Diagnostic Ultrasound Indications for Use Form
Intended use:
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
A | B | M | PWD | CWD | Color | ||||||
Doppler | Amplitude | ||||||||||
Doppler | Color | ||||||||||
Velocity | |||||||||||
Doppler | Combined | ||||||||||
(Specify) | Other | ||||||||||
(Specify) | |||||||||||
Ophthalmic | |||||||||||
Fetal | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Abdominal | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Intraoperative (specify) | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Intraoperative Neurological | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Pediatric | N | N | N | N | N | N | N | N | N (*1) | N (*2) | |
Small Organ (specify) | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Neonatal Cephalic | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Adult Cephalic | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Cardiac | N | N | N | N | N | N | N | N | N (*1) | N (*2) | |
Transesophageal | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Transrectal | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Transvaginal | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Transurethral | |||||||||||
Intravascular | |||||||||||
Peripheral Vascular | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Laparoscopic | |||||||||||
MSK Conventional | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
MSK Superficial | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Vascular Access | N | N | N | N | N | N | N | N (*1) | N (*2, *4) | ||
Nerve Block | N | N | N | N | N | N | N | N (*1) | N (*2, *3) | ||
Other (specify) |
N = New indication; P = Previously cleared
Additional Comments:
Small Organ: Breast, Thyroid, Testicle
Intraoperative: Abdominal organs and vascular
- *1. B/M, B/PWD, B/CWD, B/CFM/PWD, B/AD/PWD, B/DPD/PWD, B/CFM/CWD, B/AD/CWD, B/DPD/CWD
- Directional Power Doppler (DPD), Imaging for guidance of biopsy *2.
-
- Oneonomic for guidance of nerve block injections
*4. I maging for guidance of central or peripheral lines.
- Oneonomic for guidance of nerve block injections
SONIX MDP User Manual | |
---|---|
----------------------- | -- |
00.040.051, Revision A
Appendix C: Transdcuer Specifications
Hulda Reimer
1
(Division Sign-Off) Division of Reproductive, Abdomina Radiological D 510(k) Number
6
Diagnostic ULTRASOUND INDICATIONS FOR USE Form SA/24mm phased array 2.8 MHz transducer
Intended use:
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Doppler | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | ||||||||||
Abdominal | N | N | N | N | N | N | N | N (*1) | N (*2) | |
Intraoperative (specify) | ||||||||||
Intraoperative Neurological | ||||||||||
Pediatric | N | N | N | N | N | N | N | N (*1) | N (*2) | |
Small Organ (specify) | ||||||||||
Neonatai Cephalic | N | N | N | N | N | N | N (*1) | N (*2) | ||
Adult Cephalic | N | N | N | N | N | N | N | N (*1) | N (*2) | |
Cardiac | N | N | N | N | N | N | N | N (*1) | N (*2) | |
Transesophageal | ||||||||||
Transrectal | ||||||||||
Transvaginal | ||||||||||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral Vascular | ||||||||||
Laparoscopic | ||||||||||
MSK Conventional | ||||||||||
MSK Superficial | ||||||||||
Vascular Access | ||||||||||
Nerve Block | ||||||||||
Other (specify) |
N = New indication; P = Previously cleared
Additional Comments:
- *1. B/M, B/PWD, B/CFM/PWD, B/AD/PWD, B/AD/PWD, B/CFM/CWD, B/AD/CWD, B/DPD/CWD
*2. Directional Power Doppier (DPD)
- Directional Power Doppler (DPD)
Appendix C: Transdcuer Specifications
00.040.051, Revision A
SONIX MDP User Manual
2
Hulu Lesem
(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number ________________________________________________________________________________________________________________________________________________________________
7
Diagnostic ULTRASOUND INDICATIONS FOR USE Form Č5-2/60 convex 3.2 MHz 60mm radius transducer
Intended use:
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
A | B | M | PWD | CWD | Color | ||||||
Doppler | Amplitude | ||||||||||
Doppler | Color | ||||||||||
Velocity | |||||||||||
Doppler | Combined | ||||||||||
(Specify) | Other | ||||||||||
(Specify) | |||||||||||
Ophthalmic | |||||||||||
Fetal | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Abdominal | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Intraoperative (specify) | |||||||||||
Intraoperative Neurological | |||||||||||
Pediatric | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Small Organ (specify) | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Neonata! Cephalic | |||||||||||
Adult Cephalic | |||||||||||
Cardiac | |||||||||||
Transesophageal | |||||||||||
Transrectal | |||||||||||
Transvaginal | |||||||||||
Transurethral | |||||||||||
Intravascular | |||||||||||
Peripheral Vascular | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Laparoscopic | |||||||||||
MSK Conventional | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
MSK Superficial | N | N | N | N | N | N | N | N (*1) | N (*2) | ||
Vascular Access | |||||||||||
Nerve Block | |||||||||||
Other (specify) |
N = New indication; P = Previously cleared
Additional Comments:
Small Organ: Breast, Thyroid, Testicle
- *1. B/M, B/PWD, B/CWD, B/CFM/PWD, B/AD/PWD, B/DPD/PWD, B/CFM/CWD, B/AD/CWD, B/DFD/CWD
*2. Directional Power Doppler (DPD), Imaging for guidance of biopsy
- Directional Power Doppler (DPD), imaging for guidance of biopsy
SONIX MDP User Manual | 00.040.051, Revision A | Appendix C: Transdcuer Specifications |
---|---|---|
3 |
(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number | K080935 |
---|---|
--------------- | --------- |
8
Diagnostic ULTRASOUND INDICATIONS FOR USE Form EC9-5/10 microconvex endocavity 6.6 MHz 10mm radius transducer
Intended use:
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
A | B | M | PWD | CWD | Color | |||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Doppler | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | ||||||||||
Abdominal | ||||||||||
Intraoperative (specify) | ||||||||||
Intraoperative Neurological | ||||||||||
Pediatric | ||||||||||
Small Organ (specify) | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Cardiac | ||||||||||
Transesophageal | ||||||||||
Transrectal | N | N | N | N | N | N | N (*1) | N (*2) | ||
Transvaginal | N | N | N | N | N | N | N (*1) | N (*2) | ||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral Vascular | ||||||||||
Laparoscopic | ||||||||||
MSK Conventional | ||||||||||
MSK Superficial | ||||||||||
Vascular Access | ||||||||||
Nerve Block | ||||||||||
Other (specify) |
N = New indication; P = Previously cleared
Additional Comments:
*1. B/M, B/PWD, B/CWD, B/CFM/PWD, B/AD/PWD, B/DPD/PWD, B/CFM/CWD, B/D/CV/D, B/DPD/CWD
*2. Directional Power Doppler (DPD), Imaging for guidance of biopsy
Appendix C: Transdcuer Specifications | 00.040.051, Revision A | SONIX MDP User Manual |
---|---|---|
4 | ||
(Division Sign-Off) | ||
Division of Reproductive, Abdominal and | ||
Radiological Devices | ||
510(k) Number | 2080935 |
9
Diagnostic ULTRASOUND INDICATIONS FOR USE Form L14-5/38 linear 8 MHz 38mm transducer
Intended use:
Diagnostic uitrasound imaging or fluid flow analysis of the human body as follows:
Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | A | B | M | PWD | CWD | Color | ||||
Doppler | Amplitude | |||||||||
Doppler | Color | |||||||||
Velocity | ||||||||||
Doppler | Combined | |||||||||
(Specify) | Other | |||||||||
(Specify) | ||||||||||
Ophthalmic | ||||||||||
Fetal | N | N | N | N | N | N | N (*1) | N (*2) | ||
Abdominal | N | N | N | N | N | N | N (*1) | N (*2) | ||
Intraoperative (specify) | ||||||||||
Intraoperative Neurological | ||||||||||
Pediatric | N | N | N | N | N | N | N (*1) | N (*2) | ||
Small Organ (specify) | N | N | N | N | N | N | N (*1) | N (*2) | ||
Neonatal Cephalic | N | N | N | N | N | N | N (*1) | N (*2) | ||
Adult Cephalic | N | N | N | N | N | N | N (*1) | N (*2) | ||
Cardiac | ||||||||||
Transesophageal | ||||||||||
Transrectal | ||||||||||
Transvaginal | ||||||||||
Transurethral | ||||||||||
Intravascular | ||||||||||
Peripheral Vascular | N | N | N | N | N | N | N (*1) | N (*2) | ||
Laparoscopic | ||||||||||
MSK Conventional | N | N | N | N | N | N | N (*1) | N (*2) | ||
MSK Superficial | N | N | N | N | N | N | N (*1) | N (*2) | ||
Vascular Access | N | N | N | N | N | N | N (*1) | N (*2, *4) | ||
Nerve Block | N | N | N | N | N | N | N (*1) | N (*2, *3) | ||
Other (specify) |
N = New indication; P = Previously cleared
Additional Comments:
Small Organ: Breast, Thyroid, Testicle
-
*1. B/M, B/PWD, B/CFM/PWD, B/AD/PWD, B/OPD/PWD, B/OFM/CWD, B/AD/CWD, B/DPD/CWD
*2. Directional Power Dopbler (DPD), Imaging for guidance of biopsy
*3. Imaging for guidan
*2. Directional Power Doppler (DPD), Imaging for guidance of biops -
*4. Imaging for guidance of central or peripheral lines.
00.040.051, Revision A
5
Appendix C: Transdcuer Specifications
Hecho Leuer
(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number